NCCN Guidelines for Patients® | Mantle Cell Lymphoma

45 NCCN Guidelines for Patients ® : Mantle Cell Lymphoma, 2017 Review † † Treatment options for mantle cell lymphoma are based on the cancer stage and your health. † † For stage I and limited stage II cancers, options for first-line treatments are immunochemotherapy with or without radiation therapy and radiation therapy alone. † † Joining a clinical trial is an option if you have extensive stage II or stage III or IV cancer. Besides a clinical trial, most of these cancers are treated with immunochemotherapy alone. If your body can endure severe side effects, you may receive immunochemotherapy followed by a stem cell transplant. † † During and after cancer treatment, you may be treated to prevent or control other health conditions. Such actions are a part of supportive care. † † Follow-up care is for cancers that were fully treated. Your doctor will look for signs of cancer growth. If tests suggest cancer growth, more treatment will be needed. † † If immunochemotherapy doesn’t work as planned or the cancer returns, there are multiple treatment options. You may join a clinical trial, receive radiation therapy if not received before, or start a drug regimen that is advised by NCCN experts. 4 Treatment guide Review